Provenge minimum of 50 million autologous CD54 + cells activated with PAP-GM-CSF in Lactated Ringer's Injection, USP Images
Generic Name: sipuleucel-T
This medication has been identified as Provenge minimum of 50 million autologous CD54 + cells activated with PAP-GM-CSF in Lactated Ringer's Injection, USP and is used for Prostate Cancer. It belongs to the drug class therapeutic vaccines and is not a controlled substance.
Images of medication
Provenge
- Generic Name
- sipuleucel-T
- Strength
- minimum of 50 million autologous CD54 + cells activated with PAP-GM-CSF in Lactated Ringer's Injection, USP
- Availability
- Prescription only
- Drug Class
- Therapeutic vaccines
- Pregnancy Category
- N - Not classified
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dendreon Pharmaceuticals LLC
- National Drug Code (NDC)
- 30237-8900
See also:
More about Provenge (sipuleucel-T)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: therapeutic vaccines
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.